B3GNT5 and breast cancer: In addition, we confirmed these findings by qRT-PCR in different subtypes of breast cancer cell lines and clinical samples, showing that B3GNT5 mRNA expression was significantly higher in basal subtype of breast cancer cell lines and triple-negative breast cancer samples that are mostly also BLBC (Fig. 1 C and D).